Tumor Thickness and Determining Pathological Risk, Prognosis in BCC
A relationship between tumor thickness and histopathological growth patterns in basal cell carcinoma (BCC) investigated.
Diagnosis & Disease Information
Vismodegib Demonstrates Efficacy in Basal Cell Carcinoma
Vismodegib treatment in local advanced and metastatic basal cell carcinoma is assessed.
Skin Manifestations of Systemic Cancers
Dermatoses of the skin, and their relevance to the early detection of many systemic forms of cancer, are reviewed.
Genomic Similarities in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Found
The largest AK whole-exsome sequencing study to date is reported on.
Relatlimab-Nivolumab Fixed-Dose Combo Gets Priority Review for Melanoma
The application is supported by data from the phase 2/3 RELATIVITY-047 trial.
Model More Accurately Predicts Outcomes of Radiotherapy in Cancer Patients
The genomic-adjusted radiation dose (GARD) model predicts outcomes of radiotherapy.
Adult Cancer Survivors Have Higher Risk for Comorbid Psoriasis
A nationwide, population-based cohort study was performed to determine the rate of psoriasis in adult-onset cancer survivors.
Topical Remetinostat Reduces Disease Burden in Patients With Basal Cell Carcinoma
Remetinostat produced a complete response in 17 of 33 tumors.
Nemvaleukin Alfa Fast Tracked for Mucosal Melanoma
Nemvaleukin alfa is an investigational, engineered fusion protein consisting of modified interleukin-2 (IL-2) and the high-affinity IL-2 alpha receptor chain.
Melanoma Brain Metastases: ‘Absolutely Treatable in 2021’
Experts outline treatment options and make recommendations.
- Loading...
Loading...
Loading... 
Loading...